Literature DB >> 23210880

Extreme below-the-knee interventions: retrograde transmetatarsal or transplantar arch access for foot salvage in challenging cases of critical limb ischemia.

Luis Mariano Palena1, Marco Manzi.   

Abstract

PURPOSE: To describe advanced retrograde access (transmetatarsal or transplantar arch) for endovascular treatment of critical limb ischemia (CLI) and foot salvage.
METHODS: From September 2011 to March 2012, 28 CLI patients (24 men; mean age 71.9 ± 10.6 years) being treated for foot salvage had failed antegrade recanalization, and percutaneous retrograde access at the pedal or plantar artery was unavailable. Advanced retrograde access techniques were required to recanalize the target vessel to restore blood flow to the compromised tissue. After local administration of verapamil to control spasm, the first dorsal metatarsal artery was preferentially accessed with a 21-G needle. When the first metatarsal artery was occluded and not fluoroscopically viewable, the plantar arch was punctured directly. After puncture, a 0.018- or 0.014-inch guidewire and microsheath were inserted for retrograde recanalization of the foot and tibial arteries with balloons sized to the target vessels.
RESULTS: Retrograde transmetatarsal artery access was performed in 25 cases and direct transplantar arch access in 3. Technical success (ability to deliver the balloon across the lesion and inflate it at nominal pressure) was achieved in 24 (86%) cases, with <50% residual stenosis and no complications. The 4 technical failures were due to spasm or no true lumen re-entry after successful transmetatarsal (n=3) and transplantar arch access. During a mean 5-month follow-up (range 1-8), clinical improvement was obtained in the patients having technically successful tibial and foot artery recanalization; the transcutaneous pressure improved from 12.5 ± 6.7 to 49.8 ± 9.5 mmHg. There were no major and only 8 minor amputations. Amputation-free survival estimated by Kaplan-Meier analysis was 71% at 6 months. In patients with failed advanced access, the clinical condition did not improve.
CONCLUSION: The advanced retrograde access technique appears feasible and beneficial as a rescue strategy in challenging patients with a failed antegrade approach who are unsuitable for retrograde pedal/plantar access.

Entities:  

Mesh:

Year:  2012        PMID: 23210880     DOI: 10.1583/JEVT-12-3998R.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  7 in total

Review 1.  Treating calf and pedal vessel disease: the extremes of intervention.

Authors:  Marco Manzi; Luis M Palena
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

2.  Patency of runoff detected by MR angiography at 3.0 T with cuff-compression: a predictor of successful endovascular recanalization below the knee.

Authors:  Yue-Qi Zhu; Jun-Gong Zhao; Jue Wang; Hua-Qiao Tan; Hai-Tao Lu; Fang Liu; Ying-Sheng Cheng; Li-Ming Wei; Pei-Lei Zhang
Journal:  Eur Radiol       Date:  2014-07-31       Impact factor: 5.315

3.  Patency of the arterial pedal-plantar arch in patients with chronic kidney disease or diabetes mellitus.

Authors:  Axel Haine; Alan G Haynes; Andreas Limacher; Tim Sebastian; Wuttichai Saengprakai; Torsten Fuss; Iris Baumgartner
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-02-12

Review 4.  Treatment of infrapopliteal critical limb ischemia in 2013: the wound perfusion approach.

Authors:  Matthew C Bunte; Mehdi H Shishehbor
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

5.  Predictors for Better Blood-Flow Restoration of Long-Segmental Below-the-Knee Chronic Total Occlusions after Endovascular Therapy in Diabetic Patients.

Authors:  Xiao-Li Song; Yue-Qi Zhu; Hai-Tao Lu; Fang Liu; Li-Ming Wei; Heoung Keun Kang; Jun-Gong Zhao
Journal:  Korean J Radiol       Date:  2016-10-31       Impact factor: 3.500

Review 6.  Critical limb ischemia: current challenges and future prospects.

Authors:  Luigi Uccioli; Marco Meloni; Valentina Izzo; Laura Giurato; Stefano Merolla; Roberto Gandini
Journal:  Vasc Health Risk Manag       Date:  2018-04-26

7.  Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry.

Authors:  Michael H Vu; Glaiza-Mae Sande-Docor; Yulun Liu; Shirling Tsai; Mitul Patel; Chris Metzger; Mehdi H Shishehbor; Emmanouil S Brilakis; Nicolas W Shammas; Peter Monteleone; Subhash Banerjee
Journal:  J Interv Cardiol       Date:  2022-07-15       Impact factor: 1.776

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.